Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.

Species variations in response to urinary bladder carcinogens, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), N-ethyl-N-(4-hydroxybutyl)nitrosamine (EHBN), and N,N-dibutylnitrosamine (DBN), were investigated in several animal species from the metabolic point of view. Since N-butyl-N-(3-carboxypropyl) nitrosamine (BCPN) and N-ethyl-N-(3-carboxypropyl) nitrosamine (ECPN) had been found to be the principal urinary metabolites which are responsible for the induction of bladder tumors by BBN or DBN and EHBN, respectively, in rats, acidic urinary metabolites with the N-nitroso moiety were isolated and determined by a colorimetric method after oral administration of these nitrosamines to rats, mice, hamsters, guinea pigs, and dogs. Qualitatively almost no species differences were observed among these animals in regard to the urinary metabolites except in the case of mice, in which the glycine conjugate of BCPN was isolated from the urine and identified as the principal metabolite of BBN and DBN. However, appreciable quantitative differences in the urinary excretion of BCPN or ECPN were found among these animal species, indicating that the differences in the susceptibilities of different animal species to urinary bladder carcinogenesis induced by BBN, DBN and EHBN may be closely related to the different extents of urinary excretion of the active metabolites of these nitrosamines.

[1]  H. Otsuka,et al.  Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide. , 1981, Gan.

[2]  J. Aoki,et al.  Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder. , 1981, Gan.

[3]  M. Okada,et al.  Metabolic fate of N-alkyl-N-(3-hydroxypropyl and 2-hydroxy-ethyl)nitrosamines in the rat in relation to the induction of bladder cancer by N-butyl-N-(4-hydroxybutyl)nitrosamine and its homologs. , 1981, Gan.

[4]  M. Okada,et al.  Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder. , 1981, Gan.

[5]  M. Okada,et al.  Metabolic fate of N,N-dibutylnitrosamine in the rat. , 1980, Gan.

[6]  M. Okada,et al.  Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat. , 1980, Gan.

[7]  M. Okada,et al.  Syntheses of N-alkyl-N-(omega-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine. , 1978, Chemical and pharmaceutical bulletin.

[8]  M. Okada,et al.  Syntheses of N-alkyl-N-(hydroxy- or oxo-alkyl) nitrosamines related to N-butyl-N-(4-hydroxybutyl) nitroamine, a potent bladder carcinogen. , 1978, Chemical and pharmaceutical bulletin.

[9]  R. Oyasu,et al.  Suppression of dibutylnitrosamine-induced bladder carcinomas in hamsters by dietary indole. , 1977, Journal of the National Cancer Institute.

[10]  M. Okada,et al.  Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues. Selective induction of urinary bladder tumours in the rat. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  M. Okada,et al.  Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats. , 1976, Gan.

[12]  N. Ito.  Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. , 1976, Cancer research.

[13]  M. Hirose,et al.  Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. , 1976, Gan.

[14]  F. Krüger,et al.  Carcinogenicity of 4-hydroxybutyl-butylnitrosamine in Syrian hamsters. , 1975, Cancer letters.

[15]  Y. Hashimoto,et al.  Rapid and selective induction of urinary bladder cancer in rats with N-ethyl-N-(4-hydroxybutyl)nitrosoamine and by its principal urinary metabolite. , 1974, Gan.

[16]  K. Suzuki,et al.  Induction of urinary bladder tumors by intravesicular instillation of butyl(4-hydroxybutyl)nitrosoamine and its principal urinary metabolite, butyl(3-carboxypropyl)nitrosoamine in rats. , 1974, Gan.

[17]  A. Akagi,et al.  Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl)-nitrosoamine. , 1973, Gan.

[18]  N. Ito,et al.  Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-n-(4-hydroxybutyl)nitrosoamine. , 1973, Gan.

[19]  J. Bertram,et al.  Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. , 1972, European journal of cancer.

[20]  Y. Hashimoto,et al.  Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl-(4-hydroxybutyl)nitrosoamine. , 1972, Gan.

[21]  Y. Motomiya,et al.  Effect of DL-tryptophan on tumorigenesis in the urinary bladder and liver of rats treated with N-nitrosodibutylamine. , 1971, Gan.

[22]  D. H. Hutson,et al.  The metabolism of isopropyl oxitol in rat and dog. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  U. Mohr,et al.  Dibutylnitrosamine Carcinogenesis in Syrian Golden and Chinese Hamsters , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  D. Clayson,et al.  The carcinogenic activity of dibutylnitrosamine in IF x C57 mice. , 1970, European journal of cancer.

[25]  J. Bertram,et al.  Induction of Bladder Tumours in Mice with Dibutylnitrosamine , 1970, British Journal of Cancer.

[26]  D. Parke.  The biochemistry of foreign compounds , 1968 .

[27]  S. Ivankovic,et al.  [Liver and bladder carcinomas in the guinea pig following di-n-butylnitrosamine administration]. , 1968, Zeitschrift fur Krebsforschung.